NEXTBIOMEDICAL CO., LTD. revenue breakdown overview

NEXTBIOMEDICAL CO., LTD. revenue for the last year amounted to 9.50 B KRW, the most of which — 8.26 B KRW — came from its highest performing source at the moment, Endoscopic Hemostatic Agent, the year earlier bringing 4.27 B KRW. The greatest contribution to the revenue figure was made by Europe — last year it brought NEXTBIOMEDICAL CO., LTD. 4.40 B KRW.